NCT00827567View on ClinicalTrials.gov

Trial of RAD001 in Triple Negative Metastatic Breast Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
Breast Cancer
Interventions
DRUG

RAD 001

RAD 001-10 mg by mouth once everyday

Trial Locations (1)

17033

Penn State Milton S. Hershey Medical Center, Hershey

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Milton S. Hershey Medical Center

OTHER

NCT00827567 - Trial of RAD001 in Triple Negative Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter